Shamik Bhattacharyya, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Spinal Cord Diseases | 6 | 2024 | 290 | 3.750 |
Why?
|
| Sarcoidosis | 4 | 2023 | 514 | 1.650 |
Why?
|
| Sjogren's Syndrome | 2 | 2021 | 234 | 1.120 |
Why?
|
| Central Nervous System Diseases | 3 | 2020 | 520 | 1.020 |
Why?
|
| Lupus Erythematosus, Systemic | 5 | 2021 | 2112 | 0.960 |
Why?
|
| Encephalitis, Herpes Simplex | 1 | 2024 | 64 | 0.920 |
Why?
|
| Brain Infarction | 2 | 2017 | 299 | 0.910 |
Why?
|
| Leukoencephalopathy, Progressive Multifocal | 1 | 2023 | 132 | 0.830 |
Why?
|
| Cerebellar Diseases | 1 | 2023 | 225 | 0.790 |
Why?
|
| Arachnoiditis | 1 | 2021 | 9 | 0.790 |
Why?
|
| Neuromyelitis Optica | 2 | 2023 | 258 | 0.790 |
Why?
|
| Polyarteritis Nodosa | 1 | 2021 | 66 | 0.780 |
Why?
|
| Central Nervous System Viral Diseases | 1 | 2021 | 39 | 0.770 |
Why?
|
| Myelitis | 1 | 2021 | 52 | 0.770 |
Why?
|
| Multiple Sclerosis | 5 | 2024 | 3118 | 0.760 |
Why?
|
| Enterovirus Infections | 1 | 2021 | 72 | 0.750 |
Why?
|
| Behcet Syndrome | 1 | 2021 | 86 | 0.750 |
Why?
|
| Autoimmune Diseases | 2 | 2024 | 2183 | 0.750 |
Why?
|
| Giant Cell Arteritis | 2 | 2021 | 295 | 0.740 |
Why?
|
| Syringomyelia | 1 | 2021 | 64 | 0.740 |
Why?
|
| Arachnoid Cysts | 1 | 2021 | 58 | 0.730 |
Why?
|
| Brain Diseases | 3 | 2019 | 1558 | 0.700 |
Why?
|
| Abscess | 1 | 2023 | 609 | 0.690 |
Why?
|
| Lupus Vasculitis, Central Nervous System | 1 | 2019 | 33 | 0.670 |
Why?
|
| Spinal Cord | 4 | 2023 | 1809 | 0.670 |
Why?
|
| Brain Diseases, Metabolic | 1 | 2019 | 42 | 0.650 |
Why?
|
| Cerebral Veins | 1 | 2019 | 156 | 0.630 |
Why?
|
| Autoimmune Diseases of the Nervous System | 1 | 2018 | 70 | 0.610 |
Why?
|
| Spondylosis | 1 | 2018 | 80 | 0.600 |
Why?
|
| Apraxias | 1 | 2017 | 65 | 0.570 |
Why?
|
| Connective Tissue Diseases | 1 | 2019 | 263 | 0.540 |
Why?
|
| Vasculitis, Central Nervous System | 1 | 2016 | 42 | 0.530 |
Why?
|
| Videotape Recording | 1 | 2017 | 351 | 0.530 |
Why?
|
| Inosine | 1 | 2016 | 134 | 0.510 |
Why?
|
| Eyelids | 1 | 2017 | 265 | 0.510 |
Why?
|
| Cerebral Hemorrhage | 2 | 2023 | 2662 | 0.500 |
Why?
|
| Neurotoxicity Syndromes | 1 | 2019 | 297 | 0.490 |
Why?
|
| Frontal Lobe | 1 | 2021 | 1398 | 0.490 |
Why?
|
| Agraphia | 1 | 2014 | 8 | 0.490 |
Why?
|
| Nervous System Diseases | 2 | 2022 | 1636 | 0.480 |
Why?
|
| Neurology | 3 | 2021 | 795 | 0.470 |
Why?
|
| Cerebral Amyloid Angiopathy | 1 | 2021 | 862 | 0.460 |
Why?
|
| Sinus Thrombosis, Intracranial | 1 | 2014 | 106 | 0.440 |
Why?
|
| Spondylitis, Ankylosing | 1 | 2014 | 156 | 0.440 |
Why?
|
| Cervical Vertebrae | 2 | 2021 | 969 | 0.440 |
Why?
|
| Perceptual Disorders | 1 | 2014 | 193 | 0.420 |
Why?
|
| Gout | 1 | 2018 | 589 | 0.400 |
Why?
|
| Encephalitis | 3 | 2022 | 429 | 0.390 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2014 | 690 | 0.330 |
Why?
|
| Medical Records | 1 | 2014 | 1412 | 0.330 |
Why?
|
| Parietal Lobe | 1 | 2014 | 839 | 0.330 |
Why?
|
| Spinal Fractures | 1 | 2014 | 695 | 0.310 |
Why?
|
| Antioxidants | 1 | 2016 | 1669 | 0.310 |
Why?
|
| Ischemia | 1 | 2017 | 1924 | 0.300 |
Why?
|
| Diagnosis, Differential | 5 | 2024 | 13042 | 0.300 |
Why?
|
| Temporal Lobe | 2 | 2016 | 1683 | 0.290 |
Why?
|
| Publishing | 1 | 2014 | 840 | 0.290 |
Why?
|
| Humans | 53 | 2024 | 752741 | 0.290 |
Why?
|
| Heparin | 1 | 2014 | 1653 | 0.290 |
Why?
|
| Seizures | 2 | 2017 | 2887 | 0.280 |
Why?
|
| Cephalosporins | 2 | 2019 | 202 | 0.280 |
Why?
|
| Magnetic Resonance Imaging | 15 | 2023 | 35798 | 0.270 |
Why?
|
| Teaching Rounds | 2 | 2021 | 266 | 0.270 |
Why?
|
| Pregnancy Complications | 1 | 2019 | 2899 | 0.250 |
Why?
|
| Oxidative Stress | 1 | 2016 | 3131 | 0.240 |
Why?
|
| Middle Aged | 25 | 2024 | 216054 | 0.240 |
Why?
|
| Fibrinolytic Agents | 1 | 2014 | 2197 | 0.240 |
Why?
|
| Hippocampus | 1 | 2017 | 3713 | 0.240 |
Why?
|
| Susac Syndrome | 1 | 2023 | 22 | 0.220 |
Why?
|
| Retinal Artery Occlusion | 1 | 2023 | 80 | 0.210 |
Why?
|
| Telencephalon | 1 | 2023 | 143 | 0.210 |
Why?
|
| Demyelinating Autoimmune Diseases, CNS | 1 | 2022 | 33 | 0.200 |
Why?
|
| Parkinson Disease | 1 | 2016 | 2822 | 0.200 |
Why?
|
| Uric Acid | 2 | 2018 | 776 | 0.190 |
Why?
|
| Anti-Bacterial Agents | 2 | 2016 | 7269 | 0.190 |
Why?
|
| Meningoencephalitis | 1 | 2021 | 81 | 0.190 |
Why?
|
| Putamen | 1 | 2022 | 290 | 0.190 |
Why?
|
| Headache | 2 | 2021 | 1238 | 0.180 |
Why?
|
| Primary Ovarian Insufficiency | 1 | 2021 | 114 | 0.180 |
Why?
|
| Mesencephalon | 1 | 2022 | 330 | 0.180 |
Why?
|
| Neurologic Examination | 2 | 2021 | 929 | 0.180 |
Why?
|
| Female | 25 | 2024 | 385090 | 0.170 |
Why?
|
| Craniotomy | 1 | 2023 | 737 | 0.170 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2023 | 581 | 0.170 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2014 | 3766 | 0.160 |
Why?
|
| Male | 22 | 2024 | 354311 | 0.160 |
Why?
|
| Encephalomalacia | 1 | 2018 | 17 | 0.160 |
Why?
|
| Gadolinium | 1 | 2023 | 959 | 0.160 |
Why?
|
| Dilatation, Pathologic | 1 | 2019 | 525 | 0.160 |
Why?
|
| Opportunistic Infections | 1 | 2021 | 384 | 0.150 |
Why?
|
| Young Adult | 9 | 2024 | 57267 | 0.150 |
Why?
|
| Brain Stem | 1 | 2023 | 863 | 0.150 |
Why?
|
| Contrast Media | 2 | 2023 | 5338 | 0.150 |
Why?
|
| Optic Nerve Diseases | 1 | 2020 | 333 | 0.140 |
Why?
|
| Inappropriate ADH Syndrome | 1 | 2017 | 61 | 0.140 |
Why?
|
| Multiple Sclerosis, Relapsing-Remitting | 1 | 2022 | 528 | 0.140 |
Why?
|
| Neoplasms | 2 | 2023 | 21976 | 0.140 |
Why?
|
| Brain | 6 | 2023 | 26598 | 0.140 |
Why?
|
| Autoantibodies | 3 | 2022 | 2068 | 0.140 |
Why?
|
| Cerebellum | 1 | 2023 | 1498 | 0.140 |
Why?
|
| Flavivirus | 1 | 2015 | 20 | 0.140 |
Why?
|
| Adult | 14 | 2024 | 216658 | 0.140 |
Why?
|
| Encephalitis, Tick-Borne | 1 | 2015 | 34 | 0.130 |
Why?
|
| Encephalitis Viruses, Tick-Borne | 1 | 2015 | 40 | 0.130 |
Why?
|
| Hashimoto Disease | 1 | 2016 | 101 | 0.130 |
Why?
|
| Myelin Sheath | 1 | 2019 | 653 | 0.130 |
Why?
|
| Aged | 11 | 2024 | 165629 | 0.120 |
Why?
|
| Metronidazole | 1 | 2016 | 223 | 0.120 |
Why?
|
| Rheumatology | 1 | 2021 | 582 | 0.120 |
Why?
|
| Vaccination | 3 | 2022 | 3354 | 0.120 |
Why?
|
| Spine | 1 | 2021 | 1127 | 0.120 |
Why?
|
| Recurrence | 2 | 2023 | 8422 | 0.120 |
Why?
|
| Pituitary Gland | 1 | 2017 | 667 | 0.120 |
Why?
|
| Memory Disorders | 1 | 2021 | 1200 | 0.120 |
Why?
|
| Infertility | 1 | 2021 | 657 | 0.120 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2022 | 2901 | 0.120 |
Why?
|
| Immunoglobulin kappa-Chains | 1 | 2014 | 176 | 0.110 |
Why?
|
| Posterior Leukoencephalopathy Syndrome | 1 | 2014 | 53 | 0.110 |
Why?
|
| Vaccines | 1 | 2022 | 842 | 0.110 |
Why?
|
| Penicillins | 1 | 2016 | 387 | 0.110 |
Why?
|
| Phlebography | 1 | 2014 | 332 | 0.110 |
Why?
|
| Ataxia | 1 | 2015 | 311 | 0.110 |
Why?
|
| Treatment Outcome | 5 | 2023 | 64017 | 0.110 |
Why?
|
| Writing | 1 | 2014 | 207 | 0.110 |
Why?
|
| Thymus Neoplasms | 1 | 2015 | 278 | 0.110 |
Why?
|
| Dystonic Disorders | 1 | 2016 | 330 | 0.100 |
Why?
|
| Thiazoles | 1 | 2018 | 1484 | 0.100 |
Why?
|
| Immunosuppressive Agents | 1 | 2024 | 4121 | 0.100 |
Why?
|
| Cardiovascular System | 1 | 2018 | 834 | 0.090 |
Why?
|
| Disorders of Excessive Somnolence | 1 | 2014 | 270 | 0.090 |
Why?
|
| Medicaid | 1 | 2024 | 2776 | 0.090 |
Why?
|
| Space Perception | 1 | 2014 | 478 | 0.090 |
Why?
|
| Rare Diseases | 1 | 2016 | 605 | 0.090 |
Why?
|
| Retrospective Studies | 8 | 2024 | 78758 | 0.090 |
Why?
|
| Ambulatory Care | 1 | 2021 | 2738 | 0.090 |
Why?
|
| Comorbidity | 1 | 2024 | 10450 | 0.090 |
Why?
|
| Disease Progression | 4 | 2024 | 13364 | 0.090 |
Why?
|
| Biopsy | 1 | 2021 | 6771 | 0.080 |
Why?
|
| Education, Medical, Graduate | 1 | 2021 | 2322 | 0.080 |
Why?
|
| Diagnostic Errors | 1 | 2016 | 1270 | 0.080 |
Why?
|
| Oligopeptides | 1 | 2014 | 1211 | 0.080 |
Why?
|
| Radiation Injuries | 1 | 2016 | 1189 | 0.080 |
Why?
|
| Chronic Disease | 1 | 2023 | 9223 | 0.080 |
Why?
|
| Secondary Prevention | 1 | 2014 | 1553 | 0.070 |
Why?
|
| Functional Laterality | 1 | 2014 | 2276 | 0.070 |
Why?
|
| Neuroblastoma | 1 | 2015 | 1242 | 0.070 |
Why?
|
| Case-Control Studies | 1 | 2024 | 21904 | 0.070 |
Why?
|
| Stroke | 2 | 2021 | 10152 | 0.070 |
Why?
|
| Incidence | 1 | 2024 | 21146 | 0.070 |
Why?
|
| Cerebrovascular Circulation | 1 | 2016 | 2748 | 0.070 |
Why?
|
| Cerebral Cortex | 1 | 2022 | 5725 | 0.060 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2017 | 2776 | 0.060 |
Why?
|
| Substantia Innominata | 1 | 2023 | 24 | 0.060 |
Why?
|
| Migraine Disorders | 1 | 2016 | 1645 | 0.060 |
Why?
|
| Glioblastoma | 1 | 2018 | 3494 | 0.050 |
Why?
|
| Sensitivity and Specificity | 1 | 2018 | 14761 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3136 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3246 | 0.050 |
Why?
|
| Cross-Sectional Studies | 1 | 2023 | 25454 | 0.050 |
Why?
|
| Antigens, CD20 | 1 | 2022 | 200 | 0.050 |
Why?
|
| Proteins | 1 | 2016 | 6093 | 0.050 |
Why?
|
| Adolescent | 3 | 2024 | 86713 | 0.050 |
Why?
|
| Epilepsy | 1 | 2016 | 3319 | 0.050 |
Why?
|
| Alzheimer Disease | 1 | 2022 | 8199 | 0.050 |
Why?
|
| Dendrites | 1 | 2023 | 484 | 0.040 |
Why?
|
| Fluorescein Angiography | 1 | 2023 | 981 | 0.040 |
Why?
|
| Antibodies, Viral | 2 | 2022 | 3194 | 0.040 |
Why?
|
| United States | 2 | 2024 | 70772 | 0.040 |
Why?
|
| Delphi Technique | 1 | 2021 | 798 | 0.040 |
Why?
|
| Optic Nerve | 1 | 2020 | 558 | 0.040 |
Why?
|
| Pregnancy | 1 | 2019 | 29630 | 0.040 |
Why?
|
| Brain Neoplasms | 1 | 2018 | 8947 | 0.040 |
Why?
|
| Autopsy | 1 | 2020 | 1024 | 0.030 |
Why?
|
| Disability Evaluation | 1 | 2024 | 1842 | 0.030 |
Why?
|
| Multiple Myeloma | 1 | 2014 | 5076 | 0.030 |
Why?
|
| Fatigue | 1 | 2023 | 1536 | 0.030 |
Why?
|
| New Hampshire | 1 | 2015 | 172 | 0.030 |
Why?
|
| Ixodes | 1 | 2015 | 39 | 0.030 |
Why?
|
| Autoimmunity | 1 | 2023 | 1374 | 0.030 |
Why?
|
| Acyclovir | 1 | 2015 | 274 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2017 | 58361 | 0.030 |
Why?
|
| Nimodipine | 1 | 2014 | 55 | 0.030 |
Why?
|
| Electroencephalography | 2 | 2022 | 6117 | 0.030 |
Why?
|
| Piracetam | 1 | 2014 | 87 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2023 | 6169 | 0.030 |
Why?
|
| Meningitis, Bacterial | 1 | 2015 | 218 | 0.030 |
Why?
|
| Basal Ganglia | 1 | 2016 | 546 | 0.030 |
Why?
|
| Positron-Emission Tomography | 2 | 2022 | 6364 | 0.030 |
Why?
|
| Child | 1 | 2021 | 78594 | 0.030 |
Why?
|
| Nootropic Agents | 1 | 2014 | 159 | 0.030 |
Why?
|
| Polyneuropathies | 1 | 2014 | 137 | 0.030 |
Why?
|
| Retina | 1 | 2023 | 2636 | 0.030 |
Why?
|
| Nurses | 1 | 2021 | 2476 | 0.020 |
Why?
|
| Consensus | 1 | 2021 | 3023 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2014 | 20346 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2014 | 13678 | 0.020 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2018 | 1022 | 0.020 |
Why?
|
| Seasons | 1 | 2015 | 1511 | 0.020 |
Why?
|
| Stem Cells | 1 | 2022 | 3581 | 0.020 |
Why?
|
| Patient Satisfaction | 1 | 2021 | 3433 | 0.020 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2016 | 2033 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2021 | 13011 | 0.020 |
Why?
|
| Antihypertensive Agents | 1 | 2014 | 2083 | 0.010 |
Why?
|
| Anticonvulsants | 1 | 2014 | 1921 | 0.010 |
Why?
|
| Brain Ischemia | 1 | 2018 | 3284 | 0.010 |
Why?
|
| Disease Management | 1 | 2014 | 2473 | 0.010 |
Why?
|
| Antiviral Agents | 1 | 2015 | 3012 | 0.010 |
Why?
|
| Massachusetts | 1 | 2015 | 8721 | 0.010 |
Why?
|
| Risk Factors | 2 | 2021 | 73094 | 0.010 |
Why?
|
| Inflammation | 1 | 2021 | 10751 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2023 | 40939 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2022 | 39223 | 0.010 |
Why?
|
| Pandemics | 1 | 2020 | 8607 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2021 | 23554 | 0.010 |
Why?
|
| Prevalence | 1 | 2015 | 15404 | 0.010 |
Why?
|
| Mutation | 1 | 2023 | 29981 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2023 | 53863 | 0.010 |
Why?
|
| Prognosis | 1 | 2015 | 29264 | 0.010 |
Why?
|
| Animals | 1 | 2015 | 169600 | 0.000 |
Why?
|